The researchers have developed a simple and quick blood test for Alzheimer’s disease. The burst through method could significantly speed up the diagnosis of those who are already experiencing memory problems, allowing them to begin the drug treatment when it will still be of benefits.
The new test could accelerate the growth of revolutionary drug which meant that in future it may be possible to halt the development of the condition. The research team from US could also be jerked to pick up other infirmities from MS-multiple sclerosis and Parkinson’s disease.
Alzheimer’s and other forms of dementia affect millions and their families. The number sufferers are anticipated to be double within a generation. Currently, there is no cure for the condition and the existing drugs do not work for everyone. The current diagnosis is based memory test and costly brain scans.
However, critical evidence of the ailment typically only comes from investigating the brain after death. The study labs from all over the globe are trying to identify chemicals, proteins and antibodies which are present in the blood of the sufferers of Alzheimer’s but not in healthy individuals.
The US research team produced thousands of molecules in anticipation that some molecules would react with antibodies created by the immune systems of Alzheimer’s patients. While they sprint blood samples over synthetic molecules, three of those made strong reactions. Additional samples showed the test to be ninety-three percent correct.
They should be competent to perceive disease possibly in three to five years prior to symptoms. Patients at that early stage would provide a far higher chance of probable drugs showing apparent effects in scientific experiments. The current position, where demented people are being treated, is pretty bad since no drug is going to reverse neurodegeneration, explained researcher Thomas Kodadek.